Pfizer (PFE) Operating Income (2009 - 2026)
Pfizer's Operating Income came in at $4.27 billion for Q2 2026, down 15.6% from $5.05 billion a year earlier and down 20.3% from the prior quarter.
Pfizer (PFE) Operating Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 28, 2026, Pfizer reported Operating Income of $20.39 billion, up 1.5% year-over-year; for FY2025, it was $20.73 billion, up 16.4% from FY2024.
- Operating Income carries a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
- Going back by year, Operating Income was $17.81 billion in FY2024 (+186.9%), $6.21 billion in FY2023 (-84.6%), $40.35 billion in FY2022 (+51.7%) and $26.6 billion in FY2021 (+116.6%).
- The Q2 2026 figure represents the lowest quarterly Operating Income since Q4 2024.
- Year-over-year, Operating Income increased in four of the last six quarters, with growth averaging 19.8%.
- The fastest year-over-year change in Operating Income over five years came in Q3 2021 (growth of 137.5%), and the weakest in Q2 2023 (a decline of 73.8%).
- Business Quant data shows PFE's Operating Income at $5.35 billion (Q1 2026), $4.31 billion (Q4 2025) and $6.46 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn | 360.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 4.27 Bn |
| Mar 29, 2026 | 5.35 Bn |
| Dec 31, 2025 | 4.31 Bn |
| Sep 28, 2025 | 6.46 Bn |
| Jun 29, 2025 | 5.05 Bn |
| Mar 30, 2025 | 4.96 Bn |
| Dec 31, 2024 | 3.80 Bn |
| Sep 29, 2024 | 6.28 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 5.41 Bn |
| Dec 31, 2023 | -2.95 Bn |
| Jul 2, 2023 | 3.41 Bn |
| Apr 2, 2023 | 7.72 Bn |
| Jul 3, 2022 | 13.04 Bn |
| Apr 3, 2022 | 10.59 Bn |
| Oct 3, 2021 | 7.88 Bn |
| Jul 4, 2021 | 6.75 Bn |
| Apr 4, 2021 | 5.57 Bn |
| Dec 31, 2020 | 2.16 Bn |
| Sep 27, 2020 | 3.32 Bn |
Pfizer Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();